Medicinal Inorganic Chemistry Approaches to Passivation and Removal of Aberrant Metal Ions in Disease

被引:287
作者
Scott, Lauren E. [1 ]
Orvig, Chris [1 ]
机构
[1] Univ British Columbia, Dept Chem, Med Inorgan Chem Grp, Vancouver, BC V6T 1Z1, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
AMYLOID-BETA-PEPTIDE; BLOOD-BRAIN-BARRIER; PYRIDOXAL ISONICOTINOYL HYDRAZONE; IRON-CHELATION-THERAPY; TRANSGENIC MOUSE MODEL; ALZHEIMER A-BETA; OXIDASE INHIBITOR DRUGS; CENTRAL-NERVOUS-SYSTEM; HYDROGEN-PEROXIDE; WILSONS-DISEASE;
D O I
10.1021/cr9000176
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A study was conducted to demonstrate medicinal inorganic chemistry approaches to passivation and removal of abberant metal ions in disease. The study addressed the future of the design and utility of metal chelating drugs for disease therapy and focused on the development of therapeutics for amyotrophic lateral sclerosis (ALS), transmissible spongiform encephalopathies (TSEs), cancer, and malaria. It was revealed that the most common medicinal application of metal chelators was in the treatment of metal overload conditions. The introduced metal-binding therapeutic needed to participate in a series of ligand exchange reactions to form the new desired complex before achieving metal ion repartitioning or removal.
引用
收藏
页码:4885 / 4910
页数:26
相关论文
共 331 条
[91]   Synthesis, physicochemical properties, and biological evaluation of hydroxypyranones and hydroxypyridinones: Novel bidentate ligands for cell-labeling [J].
Ellis, BL ;
Duhme, AK ;
Hider, RC ;
Hossain, MB ;
Rizvi, S ;
vanderHelm, D .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (19) :3659-3670
[92]   Brain copper, iron, magnesium, zinc, calcium, sulfur and phosphorus storage in Wilson's disease [J].
Faa, G ;
Lisci, M ;
Caria, MP ;
Ambu, R ;
Sciot, R ;
Nurchi, VM ;
Silvagni, R ;
Diaz, A ;
Crisponi, G .
JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY, 2001, 15 (2-3) :155-160
[93]   Bioinorganic chemistry of copper and zinc ions coordinated to amyloid-β peptide [J].
Faller, Peter ;
Hureau, Christelle .
DALTON TRANSACTIONS, 2009, (07) :1080-1094
[94]   Synthesis of glycosyl derivatives as dopamine prodrugs:: interaction with glucose carrier GLUT-1 [J].
Fernández, C ;
Nieto, O ;
Fontenla, JA ;
Rivas, E ;
de Ceballos, ML ;
Fernández-Mayoralas, A .
ORGANIC & BIOMOLECULAR CHEMISTRY, 2003, 1 (05) :767-771
[95]   Monamine oxidase inhibitors: Current and emerging agents for Parkinson disease [J].
Fernandez, Hubert H. ;
Chen, Jack J. .
CLINICAL NEUROPHARMACOLOGY, 2007, 30 (03) :150-168
[96]   Global prevalence of dementia: a Delphi consensus study [J].
Ferri, CP ;
Prince, M ;
Brayne, C ;
Brodaty, H ;
Fratiglioni, L ;
Ganguli, M ;
Hall, K ;
Hasegawa, K ;
Hendrie, H ;
Huang, YQ ;
Jorm, A ;
Mathers, C ;
Menezes, PR ;
Rimmer, E ;
Scazufca, M .
LANCET, 2005, 366 (9503) :2112-2117
[97]  
Fonte J, 2001, J ALZHEIMERS DIS, V3, P209
[98]   Neuropathology of Parkinson's disease [J].
Forno, LS .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1996, 55 (03) :259-272
[99]   Synaptic release of zinc from brain slices: Factors governing release, imaging, and accurate calculation of concentration [J].
Frederickson, Christopher J. ;
Giblin, Leonard J., III ;
Rengarajan, Balaji ;
Masalha, Rafik ;
Frederickson, Cathleen J. ;
Zeng, Yaping ;
Varea Lopez, Emilio ;
Koh, Jae-Young ;
Chorin, Udi ;
Besser, Limor ;
Hershfinkel, Michal ;
Li, Yang ;
Thompson, Richard B. ;
Krezel, Artur .
JOURNAL OF NEUROSCIENCE METHODS, 2006, 154 (1-2) :19-29
[100]   The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy [J].
Gaeta, A ;
Hider, RC .
BRITISH JOURNAL OF PHARMACOLOGY, 2005, 146 (08) :1041-1059